Written question asked by John Pugh (Liberal Democrat) on Wednesday, 12 March 2008, in the House of Commons. It was due for an answer on Tuesday, 18 March 2008. It was answered by Baroness Primarolo (Labour) on Tuesday, 18 March 2008 on behalf of the Department of Health.
Seroxat
- Question
- To ask the Secretary of State for Health if he will make a statement on the use of data from clinical trials of the drug Seroxat.
- Answer
-
As per the written ministerial statement of 6 March 2008, Official Report, column 121WS, I informed the House of the outcome of the Medicines and Healthcare products Regulatory Agency investigation into Glaxosmithkline withholding relevant information gathered in clinical trials on seroxat. In the interests of public health it is important that all relevant data gathered in clinical trials of medicines is submitted promptly to the regulator.
Secondary information
- Type
- Written question
- Reference
- 473 c996W;473 c992W; 194645
- Session
- 2007-08
- Question not reached
- Yes
- Subjects
- Paroxetine Clinical trials
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2013-11-25 10:01:22 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1309968
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1309968
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1309968